Related Experiment Video

Updated: May 12, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

Quality of life in pediatric dermatology

Megan M Brown1, Sarah L Chamlin, Aimee C Smidt

  • 1Department of Dermatology, University of New Mexico School of Medicine, 1021 Medical Arts Avenue Northeast, Albuquerque, NM 87131, USA.

Dermatologic Clinics
|April 6, 2013
PubMed

Insights

Pediatric skin diseases significantly impact quality of life (QoL) for children and families. This article reviews QoL assessment tools for common pediatric skin conditions.

Area of Science:

  • Pediatric Dermatology
  • Quality of Life Research
  • Health Outcomes Assessment

Background:

  • Skin diseases impose substantial financial, psychological, social, and quality-of-life (QoL) burdens on patients.
  • Pediatric patients and their caregivers face unique vulnerabilities to the impact of skin disease.
  • Existing research has increasingly focused on developing disease-specific QoL measures in pediatric dermatology.

Purpose of the Study:

  • To provide a comprehensive overview of quality-of-life (QoL) assessment in pediatric dermatology.
  • To summarize QoL measurement tools for prevalent pediatric skin conditions.
  • To highlight the importance of QoL evaluation in managing childhood skin diseases.

Main Methods:

  • Literature review of studies on QoL assessment in pediatric dermatology.
  • Identification of disease-specific QoL indices developed over the past decade.
  • Focus on six common pediatric dermatological conditions: acne, atopic dermatitis, hemangiomas, ichthyosis, psoriasis, and vitiligo.

Main Results:

  • Several disease-specific QoL indices have been developed for pediatric dermatology.
  • Research has concentrated on conditions such as acne, atopic dermatitis, psoriasis, and vitiligo.
  • The need for robust QoL assessment in pediatric skin disease management is evident.

Conclusions:

  • Quality of life (QoL) assessment is crucial in pediatric dermatology.
  • Validated QoL tools aid in understanding the comprehensive impact of skin diseases on children.
  • Further research and application of these tools can improve patient care and outcomes.

More Related Videos

Measuring Psoriasis Severity at Home02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...